Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design
© The glucagon-like peptide 1 receptor (GLP-1R) is a class B G-protein coupled receptor (GPCR) and diabetes drug target expressed mainly in pancreatic β-cells that, when activated by its agonist glucagon-like peptide 1 (GLP-1) after a meal, stimulates insulin secretion and β-cell survival and proli...
Main Authors: | Longwell, Chelsea K., Hanna, Stephanie, Hartrampf, Nina, Sperberg, R. Andres Parra, Huang, Po-Ssu, Pentelute, Bradley L., Cochran, Jennifer R. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS)
2022
|
Online Access: | https://hdl.handle.net/1721.1/141201.2 |
Similar Items
-
Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design
by: Longwell, Chelsea K, et al.
Published: (2022) -
GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023-01-01) -
GLP-1 Receptor Agonists and Kidney Protection
by: Eulalia Valentina Greco, et al.
Published: (2019-05-01) -
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024-03-01) -
Holding GLP-1 Agonists Prior to Elective Procedures
by: Patient Safety Authority
Published: (2023-12-01)